The downgrade to Hold suggests that HSBC believes Endava's stock may not have much upside potential left, which could temper investor enthusiasm. However, the increase in the price target to $80 indicates a belief that the stock still has room to grow, albeit at a slower pace. This mixed signal could lead to a neutral short-term impact on the stock as the market digests the news.